
"I am glad that taking part in a trial might help others on their own cancer journey.”
This trial was looking at zalutumumab with radiotherapy for cancer of the mouth or cancer of the voice box (larynx) that is locally advanced.
Doctors often treat locally advanced cancer of the mouth or cancer of the larynx with chemotherapy and radiotherapy together. They most often use . But some people are not able to have platinum drugs.
Zalutumumab is a type of biological therapy called a monoclonal antibody. We knew from that zalutumumab may stop or slow down the growth of cancer cells.
The aim of this trial was to find the of zalutumumab to use with radiotherapy.
This trial was never finished so there are no results available.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Prof Chris Nutting
Experimental Cancer Medicine Centre (ECMC)
Genmab
NIHR Clinical Research Network: Cancer
Freephone 0808 800 4040
"I am glad that taking part in a trial might help others on their own cancer journey.”